Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-3-8
pubmed:abstractText
Exemestane (Aromasin) is an irreversible aromatase inactivator used for the treatment of postmenopausal women with advanced breast cancer. The objective of this study was to evaluate the effect of formulation comparing a sugar-coated tablet (SCT) with a suspension and food on the pharmacokinetics (PK) and pharmacodynamics (PD) with respect to plasma estrone sulphate (E1S) concentrations of exemestane, using a PK/PD approach.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-10735887, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-10882163, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11396363, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11668120, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11854020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12093316, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12186378, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12357147, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2124648, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2146284, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2375613, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-3289052, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-6352137, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-7479205, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8043491, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8388198, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8502825, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9274439, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9365185, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9542479, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9748124, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9815789, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9823425, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9828250, http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9871428
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
355-64
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation.
pubmed:affiliation
Department of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco, CA-94143, USA. MValle@hsp.santpau.es
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't